Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Censoring Survival Data01:09

Censoring Survival Data

Survival analysis is a statistical method used to analyze time-to-event data, often employed in fields such as medicine, engineering, and social sciences. One of the key challenges in survival analysis is dealing with incomplete data, a phenomenon known as "censoring." Censoring occurs when the event of interest (such as death, relapse, or system failure) has not occurred for some individuals by the end of the study period or is otherwise unobservable, and it might have many different reasons...
Accuracy, limits, and approximation01:28

Accuracy, limits, and approximation

Accuracy, limits, and approximations are common in many fields, especially in engineering calculations. These concepts are imperative for ensuring that a given value is as close as possible to its true value.
Accuracy is defined as the closeness of the measured value to the true or actual value. In engineering mechanics, repeated measurements are taken during theoretical or experimental analyses to ensure that the result is precise and accurate.
The accuracy of any solution is based on the...
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
Detection of Gross Error: The Q Test01:00

Detection of Gross Error: The Q Test

When one or more data points appear far from the rest of the data, there is a need to determine whether they are outliers and whether they should be eliminated from the data set to ensure an accurate representation of the measured value. In many cases, outliers arise from gross errors (or human errors) and do not accurately reflect the underlying phenomenon. In some cases, however, these apparent outliers reflect true phenomenological differences. In these cases, we can use statistical methods...
Assumptions of Survival Analysis01:15

Assumptions of Survival Analysis

Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and Cox...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Integrating Genomics and Proteomics to Identify Causal Proteins and Biologic Pathways for Incident Atrial Fibrillation in CKD.

Journal of the American Society of Nephrology : JASN·2026
Same author

Correction: Filtration Markers as Predictors of ESRD and Mortality: Individual Participant Data Meta-Analysis.

Clinical journal of the American Society of Nephrology : CJASN·2025
Same author

Proteomic Assessment of the Risk of Secondary Cardiovascular Events among Individuals with CKD.

Journal of the American Society of Nephrology : JASN·2024
Same author

Bias due to coarsening of time intervals in the inference for the effectiveness of colorectal cancer screening.

International journal of epidemiology·2024
Same author

Glycolytic lactate in diabetic kidney disease.

JCI insight·2024
Same author

Incident heart failure in chronic kidney disease: proteomics informs biology and risk stratification.

European heart journal·2024

Related Experiment Videos

G-estimation and artificial censoring: problems, challenges, and applications.

Marshall M Joffe1, Wei Peter Yang, Harold Feldman

  • 1Department of Biostatistics and Epidemiology, Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA. mjoffe@mail.med.upenn.edu

Biometrics
|September 29, 2011
PubMed
Summary
This summary is machine-generated.

G-estimation can address confounding in treatment effect studies, but artificial censoring complicates failure-time outcome analysis. This study introduces methods to improve G-estimation performance for treatment effect estimation in survival data.

Related Experiment Videos

Area of Science:

  • Biostatistics
  • Epidemiology
  • Clinical Research

Background:

  • G-estimation is a valuable method for handling confounding by treatment-affected variables.
  • Its application to failure-time outcomes is limited due to artificial censoring, which causes estimation and optimization challenges.
  • Artificial censoring can lead to non-smooth estimating functions and difficulties in finding solutions.

Purpose of the Study:

  • To enhance the performance of G-estimation for failure-time outcomes.
  • To address issues arising from artificial censoring in treatment effect estimation.
  • To propose and evaluate improved optimization strategies for G-estimation.

Main Methods:

  • Investigated methods to reduce artificial censoring.
  • Proposed substituting smooth functions for indicator functions in estimation.
  • Introduced estimating functions scaled by data information content.
  • Evaluated performance through simulation studies.
  • Considered appropriate optimization criteria for information loss.

Main Results:

  • Developed and tested novel approaches to mitigate artificial censoring in G-estimation.
  • Demonstrated improved performance of proposed methods in simulation.
  • Identified suitable optimization criteria for scenarios with information loss.
  • Successfully applied the methods to real-world data on erythropoietin and mortality.

Conclusions:

  • The proposed modifications enhance the robustness and applicability of G-estimation for failure-time outcomes.
  • These methods offer practical solutions for confounding in observational studies.
  • The study provides a framework for more reliable treatment effect estimation in survival analysis.